CDKN2A-OSK

Intervention

1 paper1 finding

  • 1 lab in 2 countries
  • 1 of 1 finding with company ties
  • Animals1

Outcomes

1

Inflammation

downin human cells1

1 study
  1. CDKN2A-OSK decreases inflammation in human cells.

    “Expression of CDKN2A-OSK in aging or stressed human primary fibroblasts led to reduced expression of inflammation-related genes”

    Cellsin aging or stressed human primary fibroblasts

    Targeted partial reprogramming of age-associated cell states improves markers of health in mouse models of aging

    Science translational medicine11 Sep 2024

More on Inflammation

Latest